Ian S. Boon

Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments

Stuart McIntosh, Fareeha Alam, Laura E. Adams et al. · The Lancet Oncology · 2023 · 120 citations · Full text

Public Affairs, Health Policy, Oncology +16

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

Evaluation of the “Shared Community Follow‐up” after a germ cell tumour—A novel initiative for remote cancer follow‐up enhanced by online patient‐reported outcome measures

Oana C. Lindner, Ian S. Boon, Johnathan Joffe et al. · European Journal of Cancer Care · 2020 · 16 citations · Full text

Medicine, Community Health, Oncology +15

Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of synthetic cannabinoid <i>black mamba</i>

Kiran Samra, Ian S. Boon, Greg Packer et al. · BMJ Case Reports · 2017 · 12 citations

Pharmacy, Neurology, Toxicology +17

Concurrent versus sequential chemoradiotherapy for unresectable locally advanced stage III non-small cell lung cancer: Retrospective analysis in a single United Kingdom cancer centre

Alice Spencer, J. Williams, Robert Samuel et al. · Cancer Treatment and Research Communications · 2021 · 11 citations · Full text

Medicine, Oncology, Radiation Oncology +17